Receive The Newest Study Notifications

QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, today announced the expansion of its U.S.-based Phase I clinical trial capabilities to support the growing needs of its pharmaceutical,...

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for orphan diseases, with an initial focus on cardiopulmonary disorders, today announced that the first patient in a Phase 2b...

Initiation of Phase 1/2 Combination Clinical Trial with Evelo’s Monoclonal Microbial, EDP1503, and KEYTRUDA® (pembrolizumab) Across Various Indications Expected in First Half of 2019 Evelo Biosciences, Inc.. a clinical-stage biotechnology company developing monoclonal...

Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2.3 of its Trial Simulator software to help drug developers improve clinical trial design, resulting in...

Multi-site clinical study brings together the best in class tumor-targeting imaging agent for brain cancer and the highest sensitivity NIR microscope-based detection device in late stage development  Blaze Bioscience Inc., the Tumor Paint Company®, a biotechnology...

Tiziana Life Sciences plc (“Tiziana” or the “Company”) (Nasdaq: TLSA / AIM: TILS), a UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, previously announced that it had submitted...

Cold Genesys, Inc. today announced that it has entered into a clinical collaboration with Merck (known as MSD outside the United States and Canada) to evaluate the combination of Cold Genesys' lead oncolytic immunotherapy candidate CG0070 with Merck’s anti-PD-1...

Clinerion has added a live heatmap to its homepage indicating prevalence of searchable disease indications by ICD10 code according to the global patient network in its Patient Network Explorer. Real-time statistics including the number of countries, sites and patients...

Knowledgent, the data intelligence company, announced today that it has launched its Intelligent Trial Planning (ITP) platform on the new AWS Marketplace for Machine Learning. Patient Recruitment delays are increasing clinical trial length within many Therapeutic...

Liu Zhihua for China Daily writes (excerpted); The company has been developing an immune cell therapy product based on a method called Expanding Activated Lymphocytes to treat solid tumor, and the clinical trial is designed to access the therapy's ability to prevent...

A recent study looking at digital patient recruitment for clinical trials found that social media in particular offers significant upside when it comes to usability for trial education and ultimately, enrollment. The study, "Content That Clicks: Effective Social...

Asia-Pacific specialist CRO Novotech announced today that clinical staff numbers in its Seoul, South Korea centre are now at 41, with 81 clinical research projects now completed. The Novotech South Korea success is largely fueled by demand for a regional CRO with...

Clinical Trial Media, a global clinical trial patient recruitment and retention, today announced that Cara Brant has taken full ownership of the company and will become Clinical Trial Media’s chief executive officer, effective immediately. Brant, who began her career...

Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed to restore the body’s innate immune system, has enrolled 10 of the 20 patients with moderate to severe Crohn’s disease...

Across every clinical trial, Pharma and Biotech have a dire need to access patients in efficient numbers and to conduct their study to the highest quality possible. Every sponsor faces the same problems, these being the lack of high performing sites available, with...

EU-funded NEPHSTROM project announces patients with diabetic kidney disease are now being enrolled in a clinical trial studying the use of a novel stromal cell immunotherapy NEPHSTROM, a large European Union Horizon 2020-funded research project coordinated by NUI...

eClinicalHealth Limited, developers of ClinpalTM, the decentralized clinical trial platform, and Dreem, a sleep neurotech company, announce the successful completion of one clinical trial validation study (Octave), and the launch of a series of clinical trials in...

NICO Corp. to install Viz Recruit, an AI based clinical trial enrollment platform at ENRICH sites to increase enrollment rates and reduce time to randomization in intracerebral hemorrhage (ICH). Viz.ai, Inc., a leading applied artificial intelligence company in...

Australia's Opthea Limited, a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, today announced that recruitment into the Company’s ongoing Phase 2b trial of OPT-302 for wet age-related macular degeneration (AMD) is...

At Biopharmadive.com, we read the following excerpt, "Many experts agree that the pharmaceutical drug development industry is on an unsustainable path. Drug development has become slower, more difficult, and more expensive. The average time to market has stagnated for...